Portfolio

The portfolio consists of 36 projects at various stages, from concept development to Phase II clinical trials and among the pharmaceutical development projects, 25 projects have reached lead-optimization phase or beyond. 14 projects are in clinical phase. Over 20 substances are assessed to have first-in-class potential.

You can view the portfolio by therapeutic area, development status, or alphabetically. Click on company names to read detailed descriptions of individual companies. Links to the companies' own websites can be found in the alphabetical section.